Drug Database
Back to search

Poland· PL-100537865

Lotemax 0,5%

A loteprednol product containing loteprednoli etabonas, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 6 of our 19 countries.

ATC S01BA14

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLotemax 0,5%ATCS01BA14REGISTER NO.PL-100537865PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about loteprednoli etabonasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Loteprednol is registered in 6 of 19 countries.

Countries holding a registration under ATC S01BA14 (loteprednol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose
Search loteprednol products by name

Loteprednol · ATC S01BA14

6 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Ireland
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Loteprednoli etabonas
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
S01BA14
ATC class
Loteprednol
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991600334

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

57 interactions on record for loteprednol.

Graded by severity as the source publishes them — 16 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check loteprednol against other medicinesHow interaction checks work

Loteprednol · interactions on record

57 records

  • 16 moderate
  • 41 info

Most severe, free to view

  • MiconazoleA07AC01moderate
  • KetoconazoleH02CA03moderate
  • ErythromycinJ01FA01moderate
  • ClarithromycinJ01FA09moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Loteprednol in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All loteprednol products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Lotemax
  • Cyprus · Lotemax
  • Czechia · Loteprednol Olikla
  • Germany · Lotemax
  • Estonia · Lotemax
  • United Kingdom (Northern Ireland) · Lotemax
  • Greece · Lotemax
  • Ireland · Lotemax
  • Italy · Lotemax, Nolok
  • Lithuania · Lotemax
  • Portugal · Xafex
  • Slovenia · Lotemax
  • Slovakia · Lotemax, Loteprednol Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0dfe9571-a420-4e56-9608-9adc0e214a9e
GET /v1/drugs/0dfe9571-a420-4e56-9608-9adc0e214a9e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do oczu, zawiesina",
  "source": "urpl",
  "strength": "0,5 %",
  "packaging": "05909991600334 ¦ Rp ¦ 166951\n1 butelka 5 ml",
  "substance": "Loteprednolu etabonian 0.5 %",
  "common_name": "Loteprednoli etabonas",
  "pl_product_id": "100537865",
  "pozwolenie_nr": "168/26",
  "auth_procedure": "IR",
  "authorisation_validity": "2031-04-29"
}
API referenceMCP serverPlans

See everything about loteprednol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console